Taiwan · Delayed Price · Currency is TWD DV Biomed Statistics
Total Valuation
DV Biomed has a market cap or net worth of TWD 1.43 billion. The enterprise value is 1.16 billion.
| Market Cap | 1.43B |
| Enterprise Value | 1.16B |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DV Biomed has 24.35 million shares outstanding. The number of shares has decreased by -0.18% in one year.
| Current Share Class | 24.35M |
| Shares Outstanding | 24.35M |
| Shares Change (YoY) | -0.18% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 15.88% |
| Owned by Institutions (%) | n/a |
| Float | 3.60M |
Valuation Ratios
The trailing PE ratio is 28.56.
| PE Ratio | 28.56 |
| Forward PE | n/a |
| PS Ratio | 2.01 |
| PB Ratio | 2.99 |
| P/TBV Ratio | 3.05 |
| P/FCF Ratio | 10.89 |
| P/OCF Ratio | 9.99 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.87, with an EV/FCF ratio of 8.85.
| EV / Earnings | 22.24 |
| EV / Sales | 1.63 |
| EV / EBITDA | 11.87 |
| EV / EBIT | 14.46 |
| EV / FCF | 8.85 |
Financial Position
The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.10.
| Current Ratio | 3.36 |
| Quick Ratio | 2.42 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.49 |
| Debt / FCF | 0.36 |
| Interest Coverage | 34.68 |
Financial Efficiency
Return on equity (ROE) is 12.84% and return on invested capital (ROIC) is 9.50%.
| Return on Equity (ROE) | 12.84% |
| Return on Assets (ROA) | 7.87% |
| Return on Invested Capital (ROIC) | 9.50% |
| Return on Capital Employed (ROCE) | 15.57% |
| Revenue Per Employee | 2.19M |
| Profits Per Employee | 160,690 |
| Employee Count | 326 |
| Asset Turnover | 1.11 |
| Inventory Turnover | 2.60 |
Taxes
In the past 12 months, DV Biomed has paid 12.57 million in taxes.
| Income Tax | 12.57M |
| Effective Tax Rate | 16.66% |
Stock Price Statistics
The stock price has increased by +13.01% in the last 52 weeks. The beta is 0.11, so DV Biomed's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | +13.01% |
| 50-Day Moving Average | 56.39 |
| 200-Day Moving Average | 58.11 |
| Relative Strength Index (RSI) | 55.75 |
| Average Volume (20 Days) | 8,312 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DV Biomed had revenue of TWD 712.61 million and earned 52.39 million in profits. Earnings per share was 2.04.
| Revenue | 712.61M |
| Gross Profit | 511.75M |
| Operating Income | 80.57M |
| Pretax Income | 75.44M |
| Net Income | 52.39M |
| EBITDA | 83.74M |
| EBIT | 80.57M |
| Earnings Per Share (EPS) | 2.04 |
Balance Sheet
The company has 317.24 million in cash and 48.04 million in debt, with a net cash position of 269.20 million or 11.06 per share.
| Cash & Cash Equivalents | 317.24M |
| Total Debt | 48.04M |
| Net Cash | 269.20M |
| Net Cash Per Share | 11.06 |
| Equity (Book Value) | 479.05M |
| Book Value Per Share | 19.67 |
| Working Capital | 342.42M |
Cash Flow
In the last 12 months, operating cash flow was 143.51 million and capital expenditures -11.80 million, giving a free cash flow of 131.70 million.
| Operating Cash Flow | 143.51M |
| Capital Expenditures | -11.80M |
| Free Cash Flow | 131.70M |
| FCF Per Share | 5.41 |
Margins
Gross margin is 71.81%, with operating and profit margins of 11.31% and 7.35%.
| Gross Margin | 71.81% |
| Operating Margin | 11.31% |
| Pretax Margin | 10.59% |
| Profit Margin | 7.35% |
| EBITDA Margin | 11.75% |
| EBIT Margin | 11.31% |
| FCF Margin | 18.48% |
Dividends & Yields
This stock pays an annual dividend of 2.37, which amounts to a dividend yield of 4.03%.
| Dividend Per Share | 2.37 |
| Dividend Yield | 4.03% |
| Dividend Growth (YoY) | -83.89% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 110.30% |
| Buyback Yield | 0.18% |
| Shareholder Yield | 4.21% |
| Earnings Yield | 3.65% |
| FCF Yield | 9.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 28, 2025. It was a forward split with a ratio of 1.18.
| Last Split Date | Aug 28, 2025 |
| Split Type | Forward |
| Split Ratio | 1.18 |
Scores
DV Biomed has an Altman Z-Score of 7.27 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.27 |
| Piotroski F-Score | 5 |